How do Orange Book listing and Hatch-Waxman suits work for brand owners?

Which patents are submitted?

Under 21 C.F.R. 314.53, the specified categories include drug-substance, drug-product, and method-of-use patents meeting the regulation's criteria. Process, packaging, metabolite, and intermediate patents are excluded from these submissions. Method-of-use information must identify the claimed approved uses as the rule requires; a company cannot simply list every patent in its portfolio.

What does a Paragraph IV notice mean?

The ANDA applicant's certification challenges the relevant patent through invalidity, unenforceability, or noninfringement, as provided by the statute. Section 355(j)(2)(B) governs notice and its detailed statement. Review the particular applicant, product, labeling, patents, and asserted basis instead of assuming each notice raises the same dispute.

When can litigation affect approval timing?

Section 355(j)(5)(B)(iii) provides a 30-month approval stay for a qualifying suit brought within 45 days after receipt of notice, subject to its patent-submission conditions and exceptions. The complaint and the FDA approval timeline are separate records. Coordinate them; an Orange Book listing is not an adjudication of validity or infringement.